Blog

by Amy DuRoss | March 2, 2020
At our core, Vineti is a technology company focused on health, well-being, and patient safety. Our software platform manages critical CAR-T cell therapies and other personalized therapeutics on behalf of patients daily. That mission-critical work…

by Amy DuRoss and Heidi Hagen | February 5, 2020
On February 5th, 2020, we announced Vineti’s $35 million Series C round of investment. A first-of-its-kind investor coalition of industry leaders -- Cardinal Health, Novartis Pharma AG, and Kite, a Gilead Company -- came together with our current…

by Amy DuRoss | January 15, 2020
Vineti, Inc., the provider of the leading digital platform of record for personalized therapeutics, today announced the appointment of John Kontor, M.D. to the company’s Board of Directors. Dr. Kontor, a clinical leader with deep experience in both…

by Marc Puich | December 30, 2019
Marc Puich has extensive experience in pharmaceutical manufacturing systems and cell therapy workflows, and is Vice President of Business Development at Vineti. This blog showcases some of the lessons learned from 100 meetings over the course of…

by Nina Kjellson, Laura Chau, and Amy DuRoss | December 17, 2019
Canaan investors, an early-stage venture capital firm that partners with founders to build the future of how we live, work and thrive. Each episode we share the journeys and wisdom of remarkable women working in life science, technology and business.…

Subscribe to our blog
Required
Required
Required
Required
Required
Required
Required

By selecting opt-in, I am agreeing to receive communications from Vineti for relevant news, updates, product information, event invitations and promotions.

You can withdraw your consent at any time by clicking the unsubscribe link in the footer of Vineti emails. Please refer to our Privacy Policy or Contact Us for more details.